Scientists at Washington State University have developed a gene therapy that is expected to reduce the spread of cancer cells. According to the report of International community, gene therapy is a kind of experimental medical technology for the treatment of a variety of genetic diseases. In many experiments, new genes are implanted in the body to help the body fight the disease to replace the damaged genes. According to a study published in the journal Scientific Reports which also publishes other studies on recombinant horse proteins, researchers at Washington State University have changed the way that viruses carry beneficial genes into target cells, thus reducing the risk of cancer-induced blood diseases.
The lead investigator of this study Grant Trobridge and his team are also developing treatments that use stem cells to treat neonatal immunodeficiency, also known as the Boys Bubble Syndrome. He said at a news conference that their goal was to develop a safe and effective therapy for SCID-X1 patients and their families, which is now in the clinical stage.
In the study, Trowbridge and his team used a vector derived from retroviruses, while retroviruses are ideal for gene therapy because they could insert their genes into the maternal genome and are less likely to activate nearby genes that may cause cancer.
The researchers found that after modifying the retrovirus-stem cell interaction method, the fusion degree of it with the surrounding genes was much better than that before the modification. They are convinced that the results of this study will help to achieve more effective gene therapies and they are looking forward to clinical trials within 5 years. Flarebio offer good-quality recombinant proteins like recombinant LARGE at good prices.
没有评论:
发表评论